Matt Sykes's questions to 10X Genomics Inc (TXG) leadership • Q1 2025
Question
An analyst on behalf of Matt Sykes asked about the potential impact of China-related tariffs, the company's mitigation strategies, and the long-term growth outlook for the region.
Answer
CFO Adam Taich stated that the company is in a fortunate position with manufacturing sites in both the U.S. and Singapore, allowing it to mitigate tariff impacts. He noted that most single-cell products are made in Singapore. The largest risk is to Xenium instruments, which are made in the U.S., but the overall impact on cost of goods sold is expected to be minimal.